Octreotide · source year
5 selected, source-linked Octreotide records carrying a 2005 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.
5 selected records.
2 represented types.
5 distinct public records.
Cited chronology
Regulatory
The official Drugs@FDA dataset lists original submission 1 for ANDA 075959 with status AP dated 2005-11-21, and names octreotide acetate among the application record's active ingredients.
Source: Drugs@FDA via openFDA ↗
Regulatory
The official Drugs@FDA dataset lists original submission 1 for ANDA 075957 with status AP dated 2005-10-03, and names octreotide acetate among the application record's active ingredients.
Source: Drugs@FDA via openFDA ↗
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT00004327 at 2026-07-30T22:50:58.187Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was octreotide.
Source: ClinicalTrials.gov ↗
Regulatory
The official Drugs@FDA dataset lists original submission 1 for ANDA 076330 with status AP dated 2005-04-08, and names octreotide acetate among the application record's active ingredients.
Source: Drugs@FDA via openFDA ↗
Regulatory
The official Drugs@FDA dataset lists original submission 1 for ANDA 076313 with status AP dated 2005-03-28, and names octreotide acetate among the application record's active ingredients.
Source: Drugs@FDA via openFDA ↗